The University of Chicago Header Logo

Connection

Sudha Yarlagadda to Antineoplastic Combined Chemotherapy Protocols

Back to Details
This is a "connection" page, showing publications Sudha Yarlagadda has written about Antineoplastic Combined Chemotherapy Protocols.
Sudha Yarlagadda
Connection Strength
0.214
Antineoplastic Combined Chemotherapy Protocols
  1. Adjuvant Chemotherapy Use for Hormone Receptor-Positive, ERBB2-Negative Breast Cancer After RxPONDER Trial. JAMA Netw Open. 2025 12 01; 8(12):e2549109.
    View in: PubMed
    Score: 0.109
  2. CDK4/6 inhibition in early and advanced hormone receptor-positive, HER2-negative breast cancer. Expert Rev Anticancer Ther. 2025 Jun; 25(6):675-686.
    View in: PubMed
    Score: 0.105
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.